02 - 03 September 2021 | London, UK

Jackie Hunter

Board Director
Jackie Hunter
Jackie Hunter has over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. Before joining BenevolentAI, Jackie was CE of the Biotechnology and Biological Sciences Research Council (BBSRC). BenevolentAI is a British held AI company which is using AI to augment the research capabilities of drug scientists, radically changing the way R&D is done.


No data was found